Combined analysis of expression of c-erbB-2, Ki-67 antigen, and tenascin provides a better prognostic indicator of carcinoma of the papilla of Vater

Pancreas

Volumn 12, Issue 2, 1996, Pages 196-201

  Vaidya, Pradeep ^a   Yosida, Toshimichi ^a   Sakakura, Teruyo ^a   Yatani, Ryuichi ^a   Noguchi, Takashi ^a   Kawarada, Yoshifumi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

c erbB 2; Carcinoma of the papilla of Vater; Ki 67 antigen; Prognostic factors; Tenascin

Indexed keywords

TENASCIN;

ADULT; AGED; ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; VATER PAPILLA CARCINOMA;

EID: 0030069164     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199603000-00015     Document Type: Article

References (17)

1. Nagakawa T. Spread and prognosis of papillary carcinoma. Dig Med 1988;8:298-304.
2. William PS, Jonathan S, Joaquin SA. Long-term follow up of 24 patients undergoing radical resection for ampullary carcinoma, 1953 to 1988. Cancer 1990;66:1717-20
3. Riyad YT Robert EH, David PV, et al. Result of surgical treatment of periampullary tumors; a thirty-five year experience. Surgery 1986;100:716-23.
4. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogteny of the catalytic domains. Science 1988;241:42-5.
5. Wright C Angus B, Nicholson S, et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 1989;49:2087-90.
6. Walker RA Gullick WJ, Varley JM. An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer. Br J Cancer 1989;60:426-9.
7. Yonemura Y, Ninomiya I, Yamaguchi A, et al. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 1991;51: 1034-8.
8. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-8.
9. Smolle J, Hofmann-Wellenhof R, Kerl H. Prognostic significance of proliferation and motility in primary malignant melanoma of the skin. J Cutan Pathol 1992;19:110-5.
10. Grogan TM, Lippman SM, Spier CM, et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 1988;71:1157-60.
11. Tujngekar MF, Gatter KC, Dunnill MS, Mason DY. Ki-67 immunostaining and survival in operable lung cancer. Histopathology 1991;19:545-50.
12. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9.
13. Mackie EJ, Chiquet-Ehrismann R, Pearson CA, et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA 1987;84:4621-5.
14. Inaguma Y, Kusalabe M, Mackie EJ, Pearson CA, Chiquet-Ehrismann R, Sakakura T. Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol 1988;128:245-55.
15. Kawarada Y, Takahashi K, Tabata M, Isaji S, Ogurai Y, Mizumoto R. Surgical treatment for carcinoma of the papilla of Vater. J Hep Bil Pancr Surg 1993;1:8-13.
16. Yamaguchi K, Enjoji M. Carcinoma of the ampulla of Vater A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer 1987; 59:506-15.
17. Willett CG, Warshaw AL, Convery K, Compton CC. Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. Surg Gynecol Obstet 1993;176:33-8.